Cargando…

Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies

MK-801, an NMDA receptor antagonist, and scopolamine, a cholinergic receptor blocker, are widely used as tool compounds to induce learning and memory deficits in animal models to study schizophrenia or Alzheimer-type dementia (AD), respectively. Memory impairments are observed after either acute or...

Descripción completa

Detalles Bibliográficos
Autores principales: Cieślik, Paulina, Siekierzycka, Anna, Radulska, Adrianna, Płoska, Agata, Burnat, Grzegorz, Brański, Piotr, Kalinowski, Leszek, Wierońska, Joanna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624219/
https://www.ncbi.nlm.nih.gov/pubmed/34830164
http://dx.doi.org/10.3390/ijms222212282
_version_ 1784606120255422464
author Cieślik, Paulina
Siekierzycka, Anna
Radulska, Adrianna
Płoska, Agata
Burnat, Grzegorz
Brański, Piotr
Kalinowski, Leszek
Wierońska, Joanna M.
author_facet Cieślik, Paulina
Siekierzycka, Anna
Radulska, Adrianna
Płoska, Agata
Burnat, Grzegorz
Brański, Piotr
Kalinowski, Leszek
Wierońska, Joanna M.
author_sort Cieślik, Paulina
collection PubMed
description MK-801, an NMDA receptor antagonist, and scopolamine, a cholinergic receptor blocker, are widely used as tool compounds to induce learning and memory deficits in animal models to study schizophrenia or Alzheimer-type dementia (AD), respectively. Memory impairments are observed after either acute or chronic administration of either compound. The present experiments were performed to study the nitric oxide (NO)-related mechanisms underlying memory dysfunction induced by acute or chronic (14 days) administration of MK-801 (0.3 mg/kg, i.p.) or scopolamine (1 mg/kg, i.p.). The levels of L-arginine and its derivatives, L-citrulline, L-glutamate, L-glutamine and L-ornithine, were measured. The expression of constitutive nitric oxide synthases (cNOS), dimethylaminohydrolase (DDAH1) and protein arginine N-methyltransferases (PMRTs) 1 and 5 was evaluated, and the impact of the studied tool compounds on cGMP production and NMDA receptors was measured. The studies were performed in both the cortex and hippocampus of mice. S-nitrosylation of selected proteins, such as GLT-1, APP and tau, was also investigated. Our results indicate that the availability of L-arginine decreased after chronic administration of MK-801 or scopolamine, as both the amino acid itself as well as its level in proportion to its derivatives (SDMA and NMMA) were decreased. Additionally, among all three methylamines, SDMA was the most abundant in the brain (~70%). Administration of either compound impaired eNOS-derived NO production, increasing the monomer levels, and had no significant impact on nNOS. Both compounds elevated DDAH1 expression, and slight decreases in PMRT1 and PMRT5 in the cortex after scopolamine (acute) and MK-801 (chronic) administration were observed in the PFC, respectively. Administration of MK-801 induced a decrease in the cGMP level in the hippocampus, accompanied by decreased NMDA expression, while increased cGMP production and decreased NMDA receptor expression were observed after scopolamine administration. Chronic MK-801 and scopolamine administration affected S-nitrosylation of GLT-1 transport protein. Our results indicate that the analyzed tool compounds used in pharmacological models of schizophrenia or AD induce changes in NO-related pathways in the brain structures involved in cognition. To some extent, the changes resemble those observed in human samples.
format Online
Article
Text
id pubmed-8624219
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86242192021-11-27 Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies Cieślik, Paulina Siekierzycka, Anna Radulska, Adrianna Płoska, Agata Burnat, Grzegorz Brański, Piotr Kalinowski, Leszek Wierońska, Joanna M. Int J Mol Sci Article MK-801, an NMDA receptor antagonist, and scopolamine, a cholinergic receptor blocker, are widely used as tool compounds to induce learning and memory deficits in animal models to study schizophrenia or Alzheimer-type dementia (AD), respectively. Memory impairments are observed after either acute or chronic administration of either compound. The present experiments were performed to study the nitric oxide (NO)-related mechanisms underlying memory dysfunction induced by acute or chronic (14 days) administration of MK-801 (0.3 mg/kg, i.p.) or scopolamine (1 mg/kg, i.p.). The levels of L-arginine and its derivatives, L-citrulline, L-glutamate, L-glutamine and L-ornithine, were measured. The expression of constitutive nitric oxide synthases (cNOS), dimethylaminohydrolase (DDAH1) and protein arginine N-methyltransferases (PMRTs) 1 and 5 was evaluated, and the impact of the studied tool compounds on cGMP production and NMDA receptors was measured. The studies were performed in both the cortex and hippocampus of mice. S-nitrosylation of selected proteins, such as GLT-1, APP and tau, was also investigated. Our results indicate that the availability of L-arginine decreased after chronic administration of MK-801 or scopolamine, as both the amino acid itself as well as its level in proportion to its derivatives (SDMA and NMMA) were decreased. Additionally, among all three methylamines, SDMA was the most abundant in the brain (~70%). Administration of either compound impaired eNOS-derived NO production, increasing the monomer levels, and had no significant impact on nNOS. Both compounds elevated DDAH1 expression, and slight decreases in PMRT1 and PMRT5 in the cortex after scopolamine (acute) and MK-801 (chronic) administration were observed in the PFC, respectively. Administration of MK-801 induced a decrease in the cGMP level in the hippocampus, accompanied by decreased NMDA expression, while increased cGMP production and decreased NMDA receptor expression were observed after scopolamine administration. Chronic MK-801 and scopolamine administration affected S-nitrosylation of GLT-1 transport protein. Our results indicate that the analyzed tool compounds used in pharmacological models of schizophrenia or AD induce changes in NO-related pathways in the brain structures involved in cognition. To some extent, the changes resemble those observed in human samples. MDPI 2021-11-13 /pmc/articles/PMC8624219/ /pubmed/34830164 http://dx.doi.org/10.3390/ijms222212282 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cieślik, Paulina
Siekierzycka, Anna
Radulska, Adrianna
Płoska, Agata
Burnat, Grzegorz
Brański, Piotr
Kalinowski, Leszek
Wierońska, Joanna M.
Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies
title Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies
title_full Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies
title_fullStr Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies
title_full_unstemmed Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies
title_short Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies
title_sort nitric oxide-dependent mechanisms underlying mk-801- or scopolamine-induced memory dysfunction in animals: mechanistic studies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624219/
https://www.ncbi.nlm.nih.gov/pubmed/34830164
http://dx.doi.org/10.3390/ijms222212282
work_keys_str_mv AT cieslikpaulina nitricoxidedependentmechanismsunderlyingmk801orscopolamineinducedmemorydysfunctioninanimalsmechanisticstudies
AT siekierzyckaanna nitricoxidedependentmechanismsunderlyingmk801orscopolamineinducedmemorydysfunctioninanimalsmechanisticstudies
AT radulskaadrianna nitricoxidedependentmechanismsunderlyingmk801orscopolamineinducedmemorydysfunctioninanimalsmechanisticstudies
AT płoskaagata nitricoxidedependentmechanismsunderlyingmk801orscopolamineinducedmemorydysfunctioninanimalsmechanisticstudies
AT burnatgrzegorz nitricoxidedependentmechanismsunderlyingmk801orscopolamineinducedmemorydysfunctioninanimalsmechanisticstudies
AT branskipiotr nitricoxidedependentmechanismsunderlyingmk801orscopolamineinducedmemorydysfunctioninanimalsmechanisticstudies
AT kalinowskileszek nitricoxidedependentmechanismsunderlyingmk801orscopolamineinducedmemorydysfunctioninanimalsmechanisticstudies
AT wieronskajoannam nitricoxidedependentmechanismsunderlyingmk801orscopolamineinducedmemorydysfunctioninanimalsmechanisticstudies